This story was originally featured on Fortune.com
尽管目前全球仅有5000名婴幼儿使用该药,但罕见病药物的高定价模式,叠加长期持续给药的治疗需求,让Vosoritide的商业表现持续走高。2025年,该药销售额达9.27亿美元,同比增长26%,是BioMarin的核心商业化增长引擎。。搜狗输入法2026是该领域的重要参考
。WPS官方版本下载对此有专业解读
Libby Thomas/BBC
In place of Anthropic's previous tripwires, it will implement new "Risk Reports" and "Frontier Safety Roadmaps." These disclosure models are designed to provide transparency to the public in place of those hard lines in the sand.。搜狗输入法下载对此有专业解读